NIH Opens Enrollment for Long COVID Clinical Trials

Symptoms, including brain fog, organ damage, and insomnia, will be studied separately.

The National Institutes of Health (NIH) opened enrollment for clinical trials exploring four potential treatments for long COVID. 

About 10 percent of adults who have had COVID-19 continue to live with long-term symptoms of the virus months or even years after their initial infection. In the first phase of long-COVID research, the institute identified four main symptoms of the illness; immune system and organ damage, brain fog and memory problems, insomnia and fatigue, and nervous system dysfunction. This second phase of the study will test individual treatments tailored to address those four areas of long-COVID.

“Clinical trials to test effective treatments and interventions are a core component of the whole-of-government response to long COVID,” said Department of Health and Human Services Assistant Secretary Levine. “Coupled with adequate supports and services, access to clinical care, and up-to-date information on what we know about long COVID, we can work toward relief for individuals and families impacted most.”

As the Lord Leads, Pray with Us…

  • For Acting Director Lawrence Tabak as he heads the National Institutes of Health.
  • For the NIH clinicians who will conduct the long-COVID trials.
  • For Assistant Secretary Levine and HHS officials as they support the research efforts.

Sources: The Hill, National Institutes of Health


Back to top